MannKind Dedicates New Insulin Production Facility Sept 17 in Danbury, CT

Friday, September 5, 2008 General News J E 4
MannKind Corporation cordially invites the press to attend a ceremony onWed Sept 17 in Danbury CT to mark completion of its new facility forproduction of the Technosphere(R) Insulin System. Start time is 10:45 am andthe main ceremony will end at approximately 12 noon.

The events in Danbury are scheduled to include an announcement of theproposed marketing trade name for the Technosphere(R) Insulin System, as wellas a ribbon cutting, luncheon, and tours. Investors, medical and industryprofessionals, scientists, and employees, and local, state, and federalgovernment officials have been invited and are expected to attend andparticipate.

In the Technosphere(R) Insulin System, insulin molecules are loaded ontothe company's proprietary Technosphere(R) particles. These loaded particlesare then aerosolized and inhaled as a dry powder into the deep lung using thecompany's proprietary MedTone(R) inhaler. Because of its rapid absorption intothe bloodstream, Technosphere(R) Insulin has the potential to become thepreferred means for controlling mealtime glucose excursions, the companybelieves.

Only guests with invitations and journalists with valid credentials whohave preregistered will be admitted to the Danbury site. To preregister as ajournalist, please contact Bill Kelly by phone or e-mail as indicated below.

For directions to the Danbury site at One Casper Street, visit Bill Kelly HarveyMalis Communications LLC 203-375-2696

SOURCE MannKind Corporation


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Zimmer Holdings, Inc. Announces Agreement to Acqui...
MiddleBrook Pharmaceuticals Announces Stockholder ...